The molecular cartography of malignant and benign sebaceous tumours
Ingrid Ferreira(Cliniques Universitaires Saint-Luc), David J. Adams(Wellcome Sanger Institute), Anca Oniscu(Karolinska University Hospital), Oliver Cast(University of Cambridge), Thomas Brenn(University of Calgary), Tobi Alegbe(Wellcome Sanger Institute), Masakazu Fujimoto(Wakayama Medical University), Mark J. Arends(Edinburgh Cancer Research), Kun Wang(University of Illinois Urbana-Champaign), Martin Del Castillo Velasco‐Herrera(Wellcome Sanger Institute), Louise van der Weyden(Wellcome Sanger Institute), Ashray Gunjur(Wellcome Sanger Institute), A. Stratigos(Andreas Sygros Hospital), Katharina Wiedemeyer(University of Calgary), Jacqueline Marcia Boccacino(Wellcome Sanger Institute), Eytan Ruppin(Cedars-Sinai Medical Center), Kim Wong(University of Washington), Ian M. Frayling(Inserm), Helen Caldwell(University of Northampton), Ishan Mehta(Wellcome Sanger Institute), Victoria Harle(Wellcome Sanger Institute), Pieter Demetter(Université Libre de Bruxelles), Kaori Koga(The University of Tokyo), Sahil Sahni(Memorial Sloan Kettering Cancer Center), Prashant Gupta(Wellcome Sanger Institute), I. Matzusaki(Wakayama Medical University), Oscar M. Rueda(University of Cambridge)
Cited by 2
Related Papers
Pan-cancer analysis of whole genomes
|Nature|2020|3.3k
The clonal and mutational evolution spectrum of primary triple-negative breast cancers
|Nature|2012|2k
The somatic mutation profiles of 2,433 breast cancers refine their genomic and transcriptomic landscapes
|Nature Communications|2016|1.8k